Johnson & Johnson - stock earnings
JNJ Upcoming estimated earnings
| Date | Low Revenue | Average Revenue | High Revenue |
|---|---|---|---|
| April 18, 2023, 12:30 p.m. | 23.2 billion | 23.7 billion | 24.5 billion |
JNJ Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020Q3 | 3.6 billion USD | 21.1 billion USD |
| 2021Q1 | 1.7 billion USD | 22.5 billion USD |
| 2021Q2 | 6.2 billion USD | 22.3 billion USD |
| 2021Q3 | 6.3 billion USD | 23.3 billion USD |
| 2021Q4 | 3.7 billion USD | 23.3 billion USD |
| 2022Q1 | 4.7 billion USD | 24.8 billion USD |
| 2022Q2 | 5.1 billion USD | 23.4 billion USD |
| 2022Q3 | 4.8 billion USD | 24.0 billion USD |
| 2022Q4 | 4.5 billion USD | 23.8 billion USD |
| 2023Q1 | 3.5 billion USD | 23.7 billion USD |
JNJ Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2017 | 1.3 billion USD | 76.5 billion USD |
| 2018 | 15.3 billion USD | 81.6 billion USD |
| 2019 | 15.1 billion USD | 82.1 billion USD |
| 2021 | 14.7 billion USD | 82.6 billion USD |
| 2022 | 20.9 billion USD | 93.8 billion USD |
| 2023 | 17.9 billion USD | 94.9 billion USD |
JNJ
List: Champions
Price: 162.34USD
Dividend Yield: 2.63%
Forward Dividend Yield: 2.77%
Payout Ratio: 41.43%
Dividend Per Share: 4.52 USD
Earnings Per Share: 10.91 USD
P/E Ratio: 25.10
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers—General
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 441.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 62
DGR3: 5.61%
DGR5: 5.79%
DGR10: 6.40%
DGR20: 9.35%